Bevacizumab in combination with atezolizumab and chemotherapy led to improvements in progression-free survival and duration ...

Around 2,400 people in England have ES-SCLC, of whom around 1,200 people will be eligible to receive Tecentriq plus carboplatin and etoposide. NICE noted that clinical trial evidence suggests ...

Roche’s hopes of extending the use of its PD-L1 inhibitor Tecentriq in triple-negative breast cancer (TNBC) have been dashed by a late-stage trial failure looking at the drug in combination with ...

Samsung Guru 1200 mobile was launched in September 2012. The phone comes with a 1.52-inch display offering a resolution of 128x128 pixels. Samsung Guru 1200 is powered by an one-core processor. The ...